Skip to main content
Menu
US

HTRF Human & Mouse Phospho-CDK1 (Thr14) Detection Kit, 10,000 Assay Points

This HTRF kit enables the cell-based quantitative detection of phosphorylated CDK1 (Cyclin-Dependent Kinase 1) at Thr14, which is an inhibitory phospho-site essential for maintaining genome integrity and preventing DNA damage during the G2-M phase transition.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Application Cell Signaling
Sample Volume 16 µL

This HTRF kit enables the cell-based quantitative detection of phosphorylated CDK1 (Cyclin-Dependent Kinase 1) at Thr14, which is an inhibitory phospho-site essential for maintaining genome integrity and preventing DNA damage during the G2-M phase transition.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 500 Assay Points
Part #:
64CDK1T4PEG
List Price
USD 2,147.00
Unit Size: 10,000 Assay Points
Part #:
64CDK1T4PEH
List Price
USD 12,490.00

Overview

This HTRF cell-based assay conveniently and accurately detects phosphorylated CDK1 at Thr14.

CDK1 (Cyclin-Dependent Kinase 1) is a member of the subfamily of CDKs that coordinate cell cycle progression in mammalian cells (also including CDK1, CDK4, and CDK6). CDK1 is a catalytic subunit of a protein kinase called the M-phase promoting factor that induces entry into mitosis. CDK1 promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins (Cyclin A, Cyclin B). Phosphorylation at Thr14 and Tyr15, resulting in inhibition of CDK1, can be carried out by Wee1 and Myt1 protein kinases. The cdc25 phosphatase may be responsible for the removal of phosphates at Thr14 and Tyr15 and subsequent activation of CDK1.

CDK1 inhibitory phosphorylation at Thr14 is essential for maintaining genome integrity and preventing DNA damage during the S phase. The Wee1/Cdc25A axis is therefore an attractive target for cancer therapy and may represent a unique approach to sensitize cancer cells with hyperactive CDK1.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 1
Lysis Buffer 4
Molecular Modification
Phosphorylation
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Mouse
Technology
TR-FRET
Unit Size
10,000 Assay Points

Video gallery

How it works

Phospho-CDK1 (Thr14) assay principle

The Phospho-CDK1 (Thr14) assay measures CDK1 when phosphorylated at Thr14. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The assay uses 2 antibodies, one labeled with a donor fluorophore and the other with an acceptor. The first antibody was selected for its specific binding to the phosphorylated motif on the protein, and the second for its ability to recognize the protein independently of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies, and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein's phosphorylation state under a no-wash assay format.

human-and-mouse-phospho

 

Phospho-CDK1 (Thr14) two-plate assay protocol

The two-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before the addition of Phospho-CDK1 (Thr14) HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

human-and-mouse-phospho-2.svg

 

Phospho-CDK1 (Thr14) one-plate assay protocol

Detection of Phosphorylated CDK1 (Thr14) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

human-and-mouse-phospho-3.svg

 

 

Assay validation

Phospho-CDK1 (Thr14) modulation using Hydroxyurea

HeLa cells were cultured in a 96-well plate (50,000 cells/well) for 6h, and then treated overnight with increasing concentration of Hydroxyurea (inducer of single strand breaks). After cell lysis, 16 µL of lysates were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-CDK1 (Thr14) or Total CDK1 detection antibodies were added. The HTRF signal was recorded after an overnight incubation.

As expected, hydroxyurea triggered a dose-dependent increase in phosphorylated CDK1 at Thr14, while the expression level of the protein was not modulated by the treatment.

human-and-mouse-phospho

 

Phospho-CDK1 (Thr14) modulation using Wee1/Myt1 inhibitor

HeLa and MCF7 cells were cultured in a 96-well plate (50,000 cells/well) for 24h, and then treated for 2h with the Wee1/Myt1 kinase inhibitor PD0166285.

After cell lysis, 16 µL of lysates were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-CDK1 (Thr14) or Total CDK1 detection antibodies were added. The HTRF signal was recorded after an overnight incubation.

As expected, the Wee1/Myt1 kinase inhibitor PD166285 decreased phosphorylated CDK1 at Thr14, while the expression level of the protein remained stable.

human-and-mouse-phospho-5.svg

 

human-and-mouse-phospho

 

Validation of Phospho-CDK1 (Thr14) assay specificity by siRNA knockdown experiments

HeLa cells were plated in a 96-well plate (10,000 cells/well) and cultured for 24h. The cells were then transfected with siRNAs specific for CDK1, CDK2, CDK3, CDK4, CDK5, or CDK6, as well as with a negative control siRNA. After a 48h incubation, the cells were lyzed. 16 µL of lysates were transferred into a 384-well low volume white microplate, and 4 µL of the HTRF Phospho-CDK1 (Thr14) detection antibodies were added. The HTRF signal was recorded after an overnight incubation.

Cell transfection with the CDK1 siRNA led to a 72% signal decrease compared to the cells transfected with the negative siRNA. On the contrary, the knockdown of CDK2, CDK3, CDK4, CDK5, or CDK6 did not induce any signal decrease, demonstrating that the HTRF Phospho-CDK1 (Thr14) assay is specific for CDK1 phosphorylation and does not cross-react with other cell cycle CDK family members.

human-and-mouse-phospho

 

Assessment of phospho CDK1 Thr14 levels in various cell lines

Adherent human & mouse cells HeLa, MCF7, and Neuro 2A, or suspension, such as THP1 cells, were seeded at 50,000 cells / well in a 96-well microplate. After a 24H incubation, the cells were lyzed with supplemented lysis buffer, and 16 µL of lysate were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF phospho CDK1 (Thr14) detection reagents. The HTRF signal was recorded after an overnight incubation.

The HTRF phospho CDK1 (Thr14) assay efficiently detected phospho CDK1 (Thr14) in various cellular models expressing different levels of the protein.

human-and-mouse-phospho

 

HTRF phospho-CDK1 (Thr14) assay compared to Western Blot

HeLa cells were cultured in a T175 flask in complete culture medium at 37°C, 5% CO2. After a 48h incubation, the cells were lyzed with 3 mL of supplemented lysis buffer #1 (1X) for 30 minutes at RT under gentle shaking.

Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF phospho-CDK1 (Thr14) detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.

Using the HTRF phospho-CDK1 (Thr14) assay, 625 cells/well were enough to detect a significant signal, while 20,000 cells were needed to obtain a minimal chemiluminescent signal using Western Blot. Therefore in these conditions, the HTRF phospho-CDK1 (Thr14) assay was 32 times more sensitive than the Western Blot technique.

human-and-mouse-phospho

 

Simplified pathway

Role of phospho-CDK1 in the cell-division cycle

CDK1 (Cyclin-Dependent Kinase 1) is a member of the subfamily of CDKs that coordinate cell cycle progression in mammalian cells (also including CDK2, CDK4, and CDK6).

Mitogenic signals, such as growth factors, trigger cells to enter the G1 phase of the cell cycle by inducing cyclin D synthesis, leading to the formation of active CDK4/6-cyclin D complexes. CDK4 and CDK6 mono-phosphorylate the protein of retinoblastoma (RB), which still binds to transcription factor E2F, but some genes can be transcribed, such as cyclin E. In the late G1 and early S phases, Cyclin E interacts with and activates CDK2, which in turn phosphorylates additional sites on RB, resulting in its complete inactivation. The E2F-responsive genes required for S phase progression are thus induced, such as Cyclin A which then interacts with CDK2 to form Cyclin A/CDK2 complexes. Activated CDK2 finally phosphorylates Cdc25B & Cdc25C phosphatases, which in turn activate CDK1, required for progression in the G2 and M phases of the cell-division cycle (centrosome maturation and separation, chromosome condensation and mitotic entry after nuclear envelope breakdown).

phospho-pathway-Phospho-CDK1-Thr14.svg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon